サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1553581

ポイントオブケア感染症検査の市場規模、シェア、動向分析レポート：技術別、疾患別、最終用途別、地域別、セグメント別予測、2024年～2030年

Point Of Care Infectious Disease Testing Market Size, Share & Trends Analysis Report By Technology, By Disease (HIV POC, Clostridium Difficile POC), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
ポイントオブケア感染症検査の市場規模、シェア、動向分析レポート：技術別、疾患別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年08月22日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ポイントオブケア感染症検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のポイントオブケア感染症検査市場規模は2030年までに157億6,000万米ドルに達し、CAGR 4.3%を記録すると予測されています。

患者中心のサービスという新たな動向と複雑な感染症の罹患率の上昇が相まって、ポータブルで正確な検出装置に対する需要が急増し、市場成長が見込まれます。感染症の迅速な検出を可能にするこれらの機器の可能性が、推定市場の要因となっています。

さらに、これらの機器によってもたらされる患者ケアの革新が、分散型検査環境に対する需要の高まりの原因となっています。新製品の研究開発と市場開拓のための投資の増加は、2025年までポイントオブケア感染症診断薬市場の発展に拍車をかけると予想されます。

例えば、EUのプロジェクト研究チームによって開発された新しい「lab-on-a-disc」技術は、マラリアを含む様々な感染症の診断に役立ちます。ポイント・オブ・ケア治療の導入により、より迅速な診断が可能になります。これにより正確な薬剤投与が可能となり、普及率に影響を与えます。

ポイントオブケア感染症検査市場レポート・ハイライト

  • COVID-19セグメントが市場を独占し、2023年には67%のシェアを占めました。この高い比率は、感染症患者数の増加と、迅速で利用しやすい診断検査ソリューションの必要性に起因しています。
  • ラテラルフローイムノアッセイは、予測期間中に最速のCAGR 5.7%を記録する見込みです。この成長の背景には、呼吸器疾患などの感染症有病率の増加と、ポイントオブケア診断装置の技術進歩があります。
  • 在宅部門は、予測期間中にCAGR 5.5％で最も急速に成長すると予測されます。これは、高齢者の間でPOC検査の採用が増加し、個別化された予防的な在宅ケア施設が重視されるようになったためです。
  • アジア太平洋地域は、政府の適切な支援による感染症の罹患率と有病率の上昇により、予測期間中に最も速い成長を示すと予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ポイントオブケア感染症検査市場の変数、動向、範囲

  • 市場イントロダクション/系統展望
  • 市場規模と成長見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ポイントオブケア感染症検査市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 ポイントオブケア感染症検査市場：技術別推定・動向分析

  • セグメントダッシュボード
  • ポイントオブケア感染症検査市場：技術別変動分析、2023年および2030年
  • ラテラルフロー免疫測定法
  • 凝集試験
  • フロースルー試験/免疫濃縮アッセイ
  • 分子診断
  • その他

第5章 ポイントオブケア感染症検査市場：疾患別推定・動向分析

  • セグメントダッシュボード
  • ポイントオブケア感染症検査市場：疾患別変動分析、2023年および2030年
  • HIV POC
  • クロストリジウム・ディフィシルPOC
  • HBV POC
  • 肺炎または連鎖球菌関連感染症
  • 呼吸器合胞体ウイルス（RSV）POC
  • HPV POC
  • インフルエンザ/インフルエンザPOC
  • HCV POC
  • MRSA POC
  • 結核と薬剤耐性結核のPOC
  • HSV POC
  • COVID-19
  • その他の感染症

第6章 ポイントオブケア感染症検査市場：最終用途別推定・動向分析

  • セグメントダッシュボード
  • ポイントオブケア感染症検査市場：最終用途別変動分析、2023年および2030年
  • クリニック
  • 病院
  • 家
  • アシステッドリビングヘルスケア施設
  • 研究室

第7章 ポイントオブケア感染症検査市場：地域別推定・動向分析

  • ポイントオブケア感染症検査市場シェア、地域別、2023年および2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • Abbott
    • Thermo Fisher Scientific Inc
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • Becton, Dickinson &Company
    • Chembio Diagnostics Inc.
    • Trinity Biotech
    • Cardinal Health
    • Quest Diagnostics Incorporated
    • Bio-Rad Laboratories Inc.
    • bioMerieux SA
    • Sight Diagnostics Ltd.
    • Gene POC
    • Trivitron Healthcare
    • OJ-Bio Ltd.
    • Ortho-Clinical Diagnostics.
目次
Product Code: GVR-1-68038-569-4

Point Of Care Infectious Disease Testing Market Growth & Trends:

The global point of care infectious disease testing market size is expected to reach USD 15.76 billion by 2030, registering a CAGR of 4.3%, according to a new report by Grand View Research, Inc. The emerging trend of patient-centric services coupled with escalating incidence rates of complicated infectious disorders is expected to upsurge the demand for portable and accurate detection devices, thus resulting in market growth. The potential in these devices to enable rapid detection of infectious diseases is attributive for the estimated market.

Moreover, revolutionizing patient care brought about by these devices is responsible for the rising demand for decentralized testing settings. Rise in the investments for R&D and development of new products is expected to spur progress in point-of-care infectious disease diagnostics market through to 2025.

For instance, development of a new 'lab-on-a-disc' technology developed by an EU project research team aids in the diagnosis of different infectious diseases including malaria. It enables faster diagnosis as a consequence of implementation of point-of-care treatment. This allows precise drugs administration thus influencing adoption rate.

Point Of Care Infectious Disease Testing Market Report Highlights:

  • COVID-19 segment dominated the market and accounted for a share of 67% in 2023. This high percentage can be attributed to the rising number of infectious cases and need for fast and accessible diagnostics testing solutions.
  • Lateral flow immunoassay is expected to register the fastest CAGR of 5.7% during the forecast period. The growth can be attributed to increasing prevalence of infectious diseases such as respiratory disease and technological advancements in point of care diagnostics device.
  • The home segment is projected to grow at the fastest CAGR of 5.5% over the forecast period, owing to increasing adoption of point of care testing among geriatric population and increasing emphasis on personalized and preventive home care facilities.
  • Asia Pacific region is expected to showcase the fastest growth over the forecast period due to rising incidence and prevalence rates of infectious diseases with suitable government support

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Point of Care Infectious Disease Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Point of Care Infectious Disease Testing Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Point of Care Infectious Disease Testing Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Point of Care Infectious Disease Testing Market: Technology Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Lateral Flow Immunoassay
    • 4.3.1. Lateral Flow Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Agglutination Test
    • 4.4.1. Agglutination Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Flow-through test/Immunoconcentration Assay
    • 4.5.1. Flow-through test/Immunoconcentration Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Molecular Diagnostics
    • 4.6.1. Molecular Diagnostics Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.7. Others
    • 4.7.1. Others Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Point of Care Infectious Disease Testing Market: Disease Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Point of Care Infectious Disease Testing Market: Disease Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. HIV POC
    • 5.3.1. HIV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Clostridium Difficile POC
    • 5.4.1. Clostridium Difficile POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. HBV POC
    • 5.5.1. HBV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Pneumonia or Streptococcus Associated Infections
    • 5.6.1. Pneumonia or Streptococcus Associated Infections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Respiratory Syncytial Virus (RSV) POC
    • 5.7.1. Respiratory Syncytial Virus (RSV) POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. HPV POC
    • 5.8.1. HPV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Influenza/Flu POC
    • 5.9.1. Influenza/Flu POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.10. HCV POC
    • 5.10.1. HCV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.11. MRSA POC
    • 5.11.1. MRSA POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.12. TB and Drug-resistant TB POC
    • 5.12.1. TB and Drug-resistant TB POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.13. HSV POC
    • 5.13.1. HSV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.14. COVID-19
    • 5.14.1. COVID-19 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.15. Other Infectious Diseases
    • 5.15.1. Other Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Point of Care Infectious Disease Testing Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Point of Care Infectious Disease Testing Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
  • 6.3. Clinics
    • 6.3.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Home
    • 6.5.1. Home Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Assisted Living Healthcare Facilities
    • 6.6.1. Assisted Living Healthcare Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Laboratory
    • 6.7.1. Laboratory Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Point of Care Infectious Disease Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Point of Care Infectious Disease Testing Market Share, By Region, 2023 & 2030 (USD Billion)
  • 7.2. North America
    • 7.2.1. North America Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.3. Europe
    • 7.3.1. Europe Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.4. France
      • 7.3.4.1. France Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3. China
      • 7.4.3.1. China Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.4. India
      • 7.4.4.1. India Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Point of Care Infectious Disease Diagnostic Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Latin America
    • 7.5.1. Latin America Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Point of Care Infectious Disease Testing Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Thermo Fisher Scientific Inc
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. F. Hoffmann-La Roche Ltd
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Siemens Healthineers
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Becton, Dickinson & Company
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Chembio Diagnostics Inc.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Trinity Biotech
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Cardinal Health
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Quest Diagnostics Incorporated
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Bio-Rad Laboratories Inc.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. bioMerieux SA
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives
    • 8.4.12. Sight Diagnostics Ltd.
      • 8.4.12.1. Participant's Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Recent Developments/ Strategic Initiatives
    • 8.4.13. Gene POC
      • 8.4.13.1. Participant's Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Recent Developments/ Strategic Initiatives
    • 8.4.14. Trivitron Healthcare
      • 8.4.14.1. Participant's Overview
      • 8.4.14.2. Financial Performance
      • 8.4.14.3. Product Benchmarking
      • 8.4.14.4. Recent Developments/ Strategic Initiatives
    • 8.4.15. OJ-Bio Ltd.
      • 8.4.15.1. Participant's Overview
      • 8.4.15.2. Financial Performance
      • 8.4.15.3. Product Benchmarking
      • 8.4.15.4. Recent Developments/ Strategic Initiatives
    • 8.4.16. Ortho-Clinical Diagnostics.
      • 8.4.16.1. Participant's Overview
      • 8.4.16.2. Financial Performance
      • 8.4.16.3. Product Benchmarking
      • 8.4.16.4. Recent Developments/ Strategic Initiatives